The Macerich Company (MAC) Stock

The Macerich Company (MAC) is a Real Estate stock trading at $23.61 (as of 2026-06-18), with a market capitalization of $5.89B and a trailing P/E of -32.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Macerich is a real estate investment trust focused on acquiring, leasing, managing, and developing or redeveloping regional shopping centers in the United States. It owns interests totaling about 51 million square feet across 47 regional malls and serves retail tenants through its mall properties.

Valuation — source: SEC EDGAR (first-party)
Price$23.61
Market Cap$5.89B
P/E Ratio-32.8
Price / Book2.46
Price / Sales6.14
Dividend Yield3.0%
DCF Value (model)$1.33
DCF Upside vs Price-94.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.01B
Net Margin-19.4%
Return on Equity-7.3%
Debt / Equity1.93
Revenue Growth (YoY)-3.1%
EPS Growth (YoY)-30.0%
Valuation vs Sector & Industry
Stock P/E-32.8
Sector P/E (Real Estate)29.8
Industry P/E (Trading)33.4
vs Sector-209.9%
vs Industry-198.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($874.30M)
Institutional Holders Tracked10
Congressional Trades (recent)3
Company
SectorReal Estate
IndustryTrading
CEOJackson Hsieh
Employees615
CountryUS
IPO Date1994-03-10

Related Companies (Business model: Equity REIT (Real Estate Investment Trust); 8 closest by market cap; US-domiciled)

  • Fermi Inc. Common Stock (FRMI)
  • Kite Realty Group Trust (KRG)
  • Millrose Properties, Inc. (MRP)
  • Phillips Edison & Company, Inc. (PECO)
  • Sabra Health Care REIT, Inc. (SBRA)
  • Howard Hughes Holdings Inc. (HHH)
  • Kilroy Realty Corporation (KRC)
  • Cousins Properties Incorporated (CUZ)
MAC earnings history · MAC institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.